Literature DB >> 3515616

Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis.

A Lasson, K Ohlsson.   

Abstract

Twenty-seven attacks of acute human pancreatitis of different severity were analysed concerning clinical outcome and activation of the coagulation and fibrinolytic systems. Consumptive coagulopathy was suggested by decreased platelet counts, decreased prothrombin values and consumption of fibrinogen during the first days in severe attacks. Factor X was slightly decreased the first 5 days in all attacks. Increased fibrinolysis was suggested by decreased plasminogen values in severe attacks. Fibrinogen degradation products were seen in 40% of the patients in blood and in 100% of the patients in the peritoneal fluid. The four main protease inhibitors of the two systems all showed protease-antiprotease complexation and lower functional than quantitative values. Plasma levels of antithrombin III and alpha 2-macroglobulin were low, while the levels of C1-inhibitor and alpha 2-antiplasmin were high. Functional levels of all the four protease inhibitors were almost zero in the peritoneal fluid in severe attacks. It is concluded that severe acute pancreatitis results in both consumptive coagulopathy and in increased fibrinolysis. A local antiprotease deficiency is seen in the peritoneal cavity and high levels of protease-antiprotease complexes are also seen in plasma. All these changes are closely correlated to the severity of the disease and may probably determine the clinical outcome of the acute attack.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515616     DOI: 10.1016/0049-3848(86)90227-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  26 in total

1.  Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs.

Authors:  K Satake; S Ha; A Hiura; H Nishiwaki; A Haku; K Umeyama
Journal:  Gastroenterol Jpn       Date:  1990-12

2.  Tissue factor in predicted severe acute pancreatitis.

Authors:  Ellen Andersson; Jakob Axelsson; Gunilla Eckerwall; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  High-mobility group box 1 protein and its role in severe acute pancreatitis.

Authors:  Xiao Shen; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

4.  Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.

Authors:  J T Wilde; W E Thomas; D A Lane; M Greaves; F E Preston
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

5.  Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.

Authors:  V Gross; J Schölmerich; H G Leser; R Salm; M Lausen; K Rückauer; U Schöffel; L Lay; A Heinisch; E H Farthmann
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

6.  An impaired phagocytic function is associated with leucocyte activation in the early stages of severe acute pancreatitis.

Authors:  G Liras; F Carballo
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

7.  Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis.

Authors:  Erdinç Cetinkaya; Kazım Senol; Barış Saylam; Mesut Tez
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 8.  Inflammation and immunosuppression in severe acute pancreatitis.

Authors:  Marja-Leena Kylänpää; Heikki Repo; Pauli Antero Puolakkainen
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

9.  Mesenteric venous infarction in acute pancreatitis.

Authors:  K Jensen; E L Bradley
Journal:  Int J Pancreatol       Date:  1989-09

10.  Protective effect of antithrombin III in acute experimental pancreatitis in rats.

Authors:  W K Bleeker; J Agterberg; G Rigter; C E Hack; J V Gool
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.